Source link : https://newshealth.biz/health-news/jak-inhibitor-stays-effective-beyond-1-year-for-giant-cell-arteritis/
(MedPage Today) — CHICAGO — Treatment of giant cell arteritis (GCA) with the oral drug upadacitinib (Rinvoq) was durably effective when continued for 2 years, results from a phase III trial extension indicated. Some 85% of patients remained… Source link : https://www.medpagetoday.com/meetingcoverage/acr/118147 Author : Publish date : 2025-10-26 21:12:00 Copyright for syndicated content belongs to […]
The post JAK Inhibitor Stays Effective Beyond 1 Year for Giant Cell Arteritis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-26 21:12:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8